Rafina Innovations, Inc. (VICA)
| Market Cap | 1.46M |
| Revenue (ttm) | 335,150 |
| Net Income (ttm) | -5.78M |
| Shares Out | 15.72M |
| EPS (ttm) | -0.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 24 |
| Last Price | $0.0530 |
| Previous Close | $0.0550 |
| Change ($) | -0.0020 |
| Change (%) | -3.64% |
| Day's Open | 0.0500 |
| Day's Range | 0.0500 - 0.0539 |
| Day's Volume | 12,179 |
| 52-Week Range | 0.0210 - 0.3960 |
Nicosia, Cyprus, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to announce C-Pharm's 1st Qu...
Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to announce C-Pharm's annual ...
Nicosia, Cyprus, May 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to officially announce the la...
Nicosia, Cyprus, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, today announced the 100% acquisition o...
About VICA
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, di... [Read more...]
| Industry Medical Devices | Founded 2007 |
| Stock Exchange OTCMKTS | Ticker Symbol VICA |
Financial Performance
In 2018, VICA's revenue was $412,682, an increase of 16.01% compared to the previous year's $355,736. Losses were -$5.85 million, 95.8% more than in 2017.